Exploring Electroporation Series Part 2: Genetic Diseases
This collection of articles explores the role of genetic engineering in understanding, preventing, and treating genetic diseases. It provides intense insight into the disease, highlighting that many health conditions stem from genomic irregularities such as single gene mutations, multifactorial disorders, and chromosomal abnormalities. The articles underscore the potential of genome editing technologies in making precise alterations to the genetic code, thereby opening the door to gene therapies that could cure genetic diseases. A key focus is MaxCyte’s electroporation technology, a leading tool in genetic engineering that delivers CRISPR systems, RNPs, and RNA molecules directly into cells for targeted gene correction. The technology's applications range from correcting genes in patient stem cells, and treating blood disorders, to developing new cell therapeutics.
If you enjoy this Cell Therapy E-book, check out the remainder of the series:
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.